This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Multiple Sclerosis/ Demyelinating Disease  • Neurology, Other  • Radiologic Imaging  • Rehabilitation Medicine  • Magnetic Resonance Imaging  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

A Multiparametric Magnetic Resonance Study

Annalisa Pulizzi, MD; Marco Rovaris, MD; Elda Judica, MD; Maria Pia Sormani, PhD; Vittorio Martinelli, MD; Giancarlo Comi, MD; Massimo Filippi, MD

Arch Neurol. 2007;64(8):1163-1168.

Objective  To investigate whether diffusion-tensor magnetic resonance imaging and whole brain N-acetylaspartate (WBNAA) proton magnetic resonance spectroscopy can provide complementary pieces of information to achieve a better understanding of the factors associated with disability in multiple sclerosis (MS).

Design  Cross-sectional survey.

Setting  Referral hospital-based MS center.

Patients  Ten healthy control subjects, 27 patients with a clinically isolated neurological syndrome, 21 patients with relapsing-remitting MS, and 29 patients with secondary progressive MS.

Main Outcome Measures  Conventional and diffusion-tensor magnetic resonance imaging, as well as WBNAA proton magnetic resonance spectroscopy, of the brain was performed. T2-hyperintense lesion volumes were measured. The mean values of mean diffusivity (MD) and fractional anisotropy of T2-visible lesions were computed. Histograms of MD and fractional anisotropy values were produced for normal-appearing white matter and gray matter (GM).

Results  Patients with a clinically isolated neurological syndrome had a significantly (P=.002) lower WBNAA concentration than control subjects. Patients with relapsing-remitting MS had significantly higher T2 lesion volume (P=.007), mean lesion MD (P=.003), normal-appearing white matter fractional anisotropy peak height (P=.03), and a lower WBNAA concentration (P<.001) than patients with a clinically isolated neurological syndrome. Patients with secondary progressive MS had significantly higher T2 lesion volume (P=.01), lower mean normal-appearing white matter fractional anisotropy (P=.003), higher mean GM MD (P=.004), and lower GM MD peak height (P=.01) than patients with relapsing-remitting MS. Disease duration, GM MD peak height, and WBNAA concentration entered a multivariate model, explaining nearly 70% of the disability variance.

Conclusions  The accumulation of macroscopic lesions and normal-appearing white matter damage seems to occur mainly during the earliest clinical phases of MS, whereas pathological features of GM may be a hallmark of the late progressive stage of the disease. This supports the notion of MS as a "2-stage" disease.

Author Affiliations: Neuroimaging Research Unit (Drs Pulizzi, Rovaris, Judica, Sormani, and Filippi) and Department of Neurology (Drs Pulizzi, Rovaris, Judica, Martinelli, Comi, and Filippi), San Raffaele Scientific Institute, Milan, Italy; and Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italy (Dr Sormani).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis
Benedetti et al.
Mult Scler 2009;15:789-794.
ABSTRACT  

Cognitive impairment and structural brain damage in benign multiple sclerosis
Rovaris et al.
Neurology 2008;71:1521-1526.
ABSTRACT | FULL TEXT